title: The role of radiation in retroperitoneal sarcomas.
abstract: Retroperitoneal sarcomas form a group of rare malignancies that require expertise in every aspect of management. Patients benefit from referral to cancer centers that can provide comprehensive, multidisciplinary, oncologic management. The role of radiation in retroperitoneal sarcoma management is, appropriately, the subject of considerable controversy due to the absence of high-level evidence proving its efficacy. Nonetheless, the preponderance of available data suggests that radiation therapy likely improves local control and, in some settings, may favorably impact resectability and survival. These outcome observations coupled with the lower doses (45-54 Gy) and normal tissue displacement characteristic of preoperative radiation therapy leads us to favor preoperative radiotherapy followed by oncologic resection for most retroperitoneal sarcomas. This strategy appears to provide the highest chance of safe and successful delivery of multimodal therapy, which can otherwise be hindered by postoperative complications as a result of technically challenging surgery and normal tissue radiation dose tolerances. Dose-escalation and selective integrative boosts to "at-risk" margins are attractive strategies that merit, and arguably require, further clinical evaluation. We believe that postoperative radiotherapy should be reserved for very high-risk cases and should be treated to a dose of ≥60 Gy respecting normal tissue dose tolerances. An additional approach that we consider in the postoperative setting is close surveillance with consideration of preoperative radiotherapy at recurrence before repeat surgical resection. Highly conformal radiotherapy techniques, such as IMRT with image guidance, should be employed to minimize dose to normal tissues and thereby allow delivery of efficacious radiation doses. If feasible, referral to a treatment facility with proton beam therapy should be discussed with the patient, especially if normal tissue dose constraints cannot be met using IMRT/IGRT. Participation in prospective studies should be highly encouraged.
authors: Department of Human Oncology, University of Wisconsin Hospital and Clinics, 600 Highland Avenue, K4/B100, Madison, WI, 53792, USA, pmohindra@uwhealth.org.
authors: Pranshu
authors: P
authors: Mohindra
authors: Heather B
authors: HB
authors: Neuman
authors: Kevin R
authors: KR
authors: Kozak
mesh_terms: D003131:Combined Modality Therapy; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000532:radiotherapy*; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D020266:Radiotherapy, Conformal; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D012509:Sarcoma / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D016896:Treatment Outcome
references: J Clin Oncol. 2009 Jan 1;27(1):24-30
references: 19047283
references: Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):127-31
references: 11316555
references: Ann Oncol. 2012 Sep;23(9):2449-2457
references: 22323436
references: Med Care. 2010 Dec;48(12):1041-9
references: 20966781
references: Cancer. 2006 Jul 15;107(2):371-9
references: 16752414
references: Ann Surg Oncol. 2007 Feb;14(2):583-90
references: 17094026
references: Ann Surg Oncol. 2002 May;9(4):346-54
references: 11986186
references: Ann Surg Oncol. 2006 Apr;13(4):508-17
references: 16491338
references: J Clin Oncol. 2009 Jan 1;27(1):31-7
references: 19047280
references: Ann Surg Oncol. 2013 Jul;20(7):2140-7
references: 23392853
references: Radiother Oncol. 2011 Apr;99(1):73-8
references: 21439664
references: Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1549-57
references: 22270176
references: Ann R Coll Surg Engl. 2011 May;93(4):275-80
references: 21944791
references: Cancer Control. 2011 Jul;18(3):177-87
references: 21666580
references: Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):164-70
references: 17084556
references: Cancer. 2010 Aug 15;116(16):3883-91
references: 20564145
references: Int J Radiat Oncol Biol Phys. 1995 Jan 1;31(1):129-34
references: 7995743
references: Ann Surg. 1995 Feb;221(2):185-95
references: 7857146
references: Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):773-9
references: 16682152
references: Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):514-9
references: 12243830
references: Arch Surg. 2010 May;145(5):426-31
references: 20479339
references: J Surg Oncol. 2010 Apr 1;101(5):345-50
references: 20119974
references: Ann Surg Oncol. 2010 Jun;17(6):1515-29
references: 20151216
references: Radiother Oncol. 2002 Dec;65(3):137-43
references: 12464441
references: Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):103-10
references: 17560050
references: Am J Clin Oncol. 2005 Jun;28(3):310-6
references: 15923806
references: J Clin Oncol. 2002 Feb 1;20(3):791-6
references: 11821462
references: Ann Surg. 1998 Sep;228(3):355-65
references: 9742918
references: J Surg Oncol. 1993 Jul;53(3):197-203
references: 7687315
references: Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1105-10
references: 19467578
references: Arch Surg. 1993 Apr;128(4):402-10
references: 8457152
references: J Surg Res. 2007 Jul;141(1):105-14
references: 17512548
references: Radiat Oncol J. 2011 Dec;29(4):260-8
references: 22984679
references: J Surg Res. 2011 Jun 15;168(2):e173-80
references: 21470630
references: J Am Coll Surg. 1996 Apr;182(4):329-39
references: 8605556
references: Br J Surg. 2007 Feb;94(2):145-61
references: 17256810
references: ANZ J Surg. 2013 May;83(5):336-41
references: 22943678
references: Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1128-34
references: 21664065
references: Surgery. 1985 Mar;97(3):316-25
references: 3975851
references: BMC Cancer. 2012 Jul 12;12:287
references: 22788989
references: Cancer. 2001 Jul 15;92(2):359-68
references: 11466691
references: Ann Surg. 1984 Aug;200(2):200-4
references: 6465975
references: Lancet. 2002 Jun 29;359(9325):2235-41
references: 12103287
references: J Clin Oncol. 2007 Jul 1;25(19):2755-63
references: 17602081
references: Cancer. 2006 Apr 1;106(7):1610-6
references: 16518798
references: Radiother Oncol. 2006 Oct;81(1):81-7
references: 17005280
references: Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):158-63
references: 17084545
references: J Clin Oncol. 2002 Jun 15;20(12):2824-31
references: 12065559
references: Arch Surg. 1991 Mar;126(3):328-34
references: 1998475
references: Cancer. 2011 Oct 1;117(19):4355-64
references: 21446048
references: Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):469-75
references: 11872294
references: Cancer Radiother. 2012 May;16(3):194-200
references: 22387193
references: Ann Surg. 2009 Dec;250(6):970-6
references: 19644351
references: Ann Oncol. 2013 Mar;24(3):832-7
references: 23123508
references: Am J Clin Oncol. 2011 Oct;34(5):511-6
references: 21127412
references: Oncologist. 2012;17(9):1213-20
references: 22907974